Concepedia

Anne Lamontagne

AL

Statistics

Publications

11

Citations

2.1K

H-Index

11

Active since

2011

Affiliations

University of Pennsylvania(Current)

Drexel University

Massachusetts General Hospital

Harvard University

Parker Institute for Cancer Immunotherapy

Anne Lamontagne is an author at University of Pennsylvania specializing in life sciences, cancer immunotherapy, and immunology.

ORCID

Publications per year

2011–2022

11

Publications

11

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text

, , +17

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma

Alfred L. Garfall, Edward A. Stadtmauer, Wei‐Ting Hwang et al. · JCI Insight · 2018 · 198 citations · Full text

, , +17

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

Saar Gill, Vanessa Vides, Noelle V. Frey et al. · Blood Advances · 2022 · 126 citations · Full text

, , +17

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood–brain barrier through paracellular transmigration and ERK activation

Divya Sagar, Anne Lamontagne, Catherine A. Foss et al. · Journal of Neuroinflammation · 2012 · 104 citations · Full text

, , +17

Prospective Clinical Trial of Anti-CD19 CAR T Cells in Combination with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia Shows a High Response Rate

Saar Gill, Vanessa Vides, Noelle V. Frey et al. · Blood · 2018 · 83 citations

, , +17

1–5 of 11